Drug Profile
Ribavirin - PENDOPHARM
Alternative Names: IBAVYR; RBV - PENDOPHARMLatest Information Update: 07 Nov 2021
Price :
$50
*
At a glance
- Originator PENDOPHARM
- Class Antivirals; Furans; Ribonucleosides; Small molecules; Triazoles
- Mechanism of Action Nucleic acid inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis C
Most Recent Events
- 18 Jul 2014 Launched for Hepatitis C in Canada (PO)
- 15 Jul 2014 Registered for Hepatitis C in Canada (PO)
- 31 Mar 2014 Clinical trials in Hepatitis C in Canada (Oral)